Decolonization of methicillin-resistant Staphylococcus aureus during routine hospital care: Efficacy and long-term follow-up

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 21, Issue 1, 2010, Pages 38-44

  Dow, Gordon ^a,b   Field, Deanna ^a   Mancuso, Michelina ^b,c   Allard, Jacques ^d  

^a MONCTON HOSPITAL   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c HORIZON HEALTH NETWORK   (Canada)

^d UNIVERSITÉ DE MONCTON   (Canada)

Author keywords

Decolonization; Efficacy; Long term; MRSA

Indexed keywords

CHLORHEXIDINE; COTRIMOXAZOLE; PSEUDOMONIC ACID; RIFAMPICIN;

AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATION; CONTROLLED STUDY; DECOLORIZATION; FEMALE; FOLLOW UP; HOSPITAL CARE; HUMAN; HYGIENE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; THERAPY EFFECT;

EID: 77950791134     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2010/590530     Document Type: Article

References (26)

1. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial blood stream infections in US hospitals: Analysis of 24,179 cases from a prospective national surveillance study. Clin Infect Dis 2004;39:309-317
2. Herwaldt LA. Control of methicillin-resistant Staphylococcus aureus in the hospital setting. Am J Med 1999;106:115-185
3. Anonymous. Report: Deaths involving MRSA: England and Wales, 2000-2004. Health Stat Q 2006;29:63-68
4. Simor AE, Ofner-Agostini M, Gravel D, et al. Surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals in a report update from the Canadian Nosocomial Infection Surveillance Program. Can Commun Dis Rep 2005;31:33-40.
5. Bisognano C, Vaudaux PE, Rohner P, Lew DP, Hooper DC. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 2000;44:1428-1437
6. Sanford MD, Widmer AF, Bale MJ, Jones RN, Wenzel RP. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1994;19:1123-1128
7. Huang S, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003;36:281-285
8. Datta R, Huang S. Risk of infection and death due to methicillin- resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 2008;47:176-181
9. Harbarth S. Control of endemic methicillin-resistant Staphylococcus aureus - recent advances and future challenges. Clin Microbiol Infect 2006;12:1154-1162
10. Boyce JM, Jackson MM, Pugliese G, et al. Methicillin-resistant Staphylococcus aureus (MRSA): A briefing for acute care hospitals and nursing facilities. Infect Control Hosp Epidemiol 1994;15:105-115
11. Vriens M, Blok H, Gigengack-Baars A, Mascini E, van der Werken C, Verhoef J, Troelstra A. Methicillin-resistant Staphylococcus aureus carriage among patients after hospital discharge. Infect Control Hosp Epidemiol 2005;26:629-633
12. Boyce JM. MRSA patients: Proven methods to treat colonization and infection. J Hosp Infect 2001;48(Suppl A):S9-14.
13. Loeb, M, Main C, Walker-Dilks C, Early A. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst Rev 2003;(4):CD003340
14. Fung S, Louie M, Simor A. Combined topical and oral antimicrobial therapy for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) colonization in hospitalized patients. Can J Infect Dis 2002;13:287-292
15. Kallen AJ, Wilson CT, Larson RJ. Perioperative intranasal mupirocin for the prevention of surgical site infections: Systematic review of the literature and meta-analysis. Infect Control Hosp Epidemiol 2005;26:916-922
16. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, et al. Surgical site infections in orthopedic surgery: The effect of mupirocin nasal ointment in a double-blind randomized, placebo-controlled study. Clin Infect Dis 2002;35:353-358
17. Wertheim HF, Vos MC, Ott A, et al. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients. A randomized study. Ann Intern Med 2004;140:419-425
18. Simor AE, Phillips E, McGeer A, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007;44:178-185
19. Cookson BD. The emergence of mupirocin resistance: A challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother 1998;41:11-18
20. Tomic V, Svetina Sorli P, Trinkaus D, Sorli J, Widmer AF, Trampuz A. Comprehensive strategy to prevent nosocomial spread of methicillin-resistant Staphylococcus aureus in a highly endemic setting. Arch Intern Med 2004;164:2038-2043
21. Darouiche R, Wright C, Hamill R, Koza M, Lewis D, Markowski J. Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline-rifampin and topical mupirocin. Antimicrob Agents Chemother 1991;35:1612-1615
22. Dietze B, Rath A, Wendt C, Martiny H. Survival of MRSA on sterile goods packaging. J Hosp Infect 2001;49:255-261
23. Ryan DM. Pharmacokinetics of antibiotics in natural and experimental superficial compartments in animals and humans. J Antimicrob Chemother 1993;31:1-16.
24. Shorr A, Tabak Y, Gupta V, Johannes R, Liu L, Kollef M. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care 2006;10:97.
25. Kim T, Oh PI, Simor AE. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2000;22:99-104.
26. Wilcox MH, Cunniffe JG, Trundle C, Redpath C. Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 1996;34:23-30.